MoneyWorks4Me

Mercury Laboratories - Quaterly Results

14 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 206.59 millions, up 18.96% as compared to Rs. 173.67 millions during the corresponding quarter last year.A big decline of -41.88% was reported for the quarter ended March 2025 to Rs. 11.10  millions from Rs. 19.10 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 23.08 millions from 30.62 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 206.59 173.67 18.96 751.01 755.59 -0.61 751.01 755.59 -0.61
Other Income 1.84 4.11 -55.23 10.69 10.88 -1.75 10.69 10.88 -1.75
PBIDT 23.08 30.62 -24.62 80.85 101.20 -20.11 80.85 101.20 -20.11
Interest 1.31 0.97 35.05 5.48 3.83 43.08 5.48 3.83 43.08
PBDT 21.77 29.65 -26.58 75.37 97.37 -22.59 75.37 97.37 -22.59
Depreciation 7.30 7.16 1.96 28.76 28.16 2.13 28.76 28.16 2.13
PBT 14.47 22.49 -35.66 46.61 69.21 -32.65 46.61 69.21 -32.65
TAX 3.37 3.39 -0.59 15.16 12.66 19.75 15.16 12.66 19.75
Deferred Tax 4.51 -0.99 -555.56 1.68 -6.34 -126.50 1.68 -6.34 -126.50
PAT 11.10 19.10 -41.88 31.45 56.55 -44.39 31.45 56.55 -44.39
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 11.17 17.63 -36.64 10.77 13.39 -19.62 10.77 13.39 -19.62
Peers
Company Name CMP
Sun Pharma. Inds. 1840.90
Dr. Reddys Labs. 1244.20
Cipla 1385.55
Lupin 2080.35
Zydus Lifesciences 1213.75
View more..